Literature DB >> 15014962

[Hereditary retinochoroidal dystrophies. Part 2: differential diagnosis].

U Kellner1, A B Renner, H Tillack.   

Abstract

A generally accepted classification for inherited retinochoroidal dystrophies does not exist. The names given to certain disorders are either based on ophthalmoscopic findings, or on histologic, electrophysiologic and genetic findings. Future research on the molecular genetic background will result in better definition of clinical entities. The purpose of this project is to outline a practical approach to inherited retinochoroidal dystrophies. For this reason, disorders with similar clinical symptoms are grouped together. Generalized retinochoroidal dystrophies affecting all retinal areas can be distinguished from regional dystrophies. Generalized dystrophies can be subdivided into those with peripheral onset, usually associated with initial rod function loss (night blindness, peripheral field loss: e.g. retinitis pigmentosa, choroideremia) and those with central onset associated with cone function loss (visual acuity loss, central scotoma, color vision deficits: e.g. cone or cone-rod dystrophies). Regionally limited dystrophies include the multitude of macular dystrophies and the autosomal dominant vitreoretinochoroidopathy, which remains limited to the periphery. It is important for a differential diagnosis to exclude involvement of other organ systems in syndromic disorders. Stationary inherited retinal dysfunction (e.g. monochromatism, congenital stationary night blindness) and other inherited or acquired diseases have to be excluded as well. Guidelines for differential diagnosis are presented.

Entities:  

Mesh:

Year:  2004        PMID: 15014962     DOI: 10.1007/s00347-003-0945-5

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  23 in total

Review 1.  Bardet-Biedl syndrome and Usher syndrome.

Authors:  Rainer Koenig
Journal:  Dev Ophthalmol       Date:  2003

2.  Visual function in patients with cone-rod dystrophy (CRD) associated with mutations in the ABCA4(ABCR) gene.

Authors:  D G Birch; A Y Peters; K L Locke; R Spencer; C F Megarity; G H Travis
Journal:  Exp Eye Res       Date:  2001-12       Impact factor: 3.467

3.  Clinical expression of Best's vitelliform macular dystrophy in Swedish families with mutations in the bestrophin gene.

Authors:  V Ponjavic; L Eksandh; S Andréasson; K Sjöström; B Bakall; S Ingvast; C Wadelius; B Ehinger
Journal:  Ophthalmic Genet       Date:  1999-12       Impact factor: 1.803

Review 4.  X linked retinoschisis.

Authors:  N D George; J R Yates; A T Moore
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

Review 5.  Molecular genetics of Leber congenital amaurosis.

Authors:  Frans P M Cremers; José A J M van den Hurk; Anneke I den Hollander
Journal:  Hum Mol Genet       Date:  2002-05-15       Impact factor: 6.150

6.  Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson Memorial Lecture.

Authors:  T P Dryja
Journal:  Am J Ophthalmol       Date:  2000-11       Impact factor: 5.258

7.  Visual acuity loss and clinical observations in a large series of patients with Stargardt disease.

Authors:  Ygal Rotenstreich; Gerald A Fishman; Robert J Anderson
Journal:  Ophthalmology       Date:  2003-06       Impact factor: 12.079

8.  Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.

Authors:  D G Birch; J L Anderson; G E Fish
Journal:  Ophthalmology       Date:  1999-02       Impact factor: 12.079

9.  Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation.

Authors:  Koji M Nishiguchi; Michael A Sandberg; Aart C Kooijman; Kirill A Martemyanov; Jan W R Pott; Stephanie A Hagstrom; Vadim Y Arshavsky; Eliot L Berson; Thaddeus P Dryja
Journal:  Nature       Date:  2004-01-01       Impact factor: 49.962

10.  Infantile and childhood retinal blindness: a molecular perspective (The Franceschetti Lecture).

Authors:  Richard G Weleber
Journal:  Ophthalmic Genet       Date:  2002-06       Impact factor: 1.803

View more
  4 in total

1.  [A 37-year-old man with peripheral retinal dystrophy].

Authors:  K Müller; W Rasche; H Tegetmeyer; C Jochmann; P Wiedemann
Journal:  Ophthalmologe       Date:  2016-02       Impact factor: 1.059

2.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

Review 3.  [Imaging and molecular genetic diagnostics for the characterization of retinal dystrophies].

Authors:  J Birtel; M Gliem; F G Holz; P Herrmann
Journal:  Ophthalmologe       Date:  2018-12       Impact factor: 1.059

4.  Dorzolamide chlorhydrate versus acetazolamide in the management of chronic macular edema in patients with retinitis pigmentosa: description of three case reports.

Authors:  Elena Pacella; Loredana Arrico; Valentina Santamaria; Paolo Turchetti; Maria Rosaria Carbotti; Giuseppe La Torre; Fernanda Pacella
Journal:  Ophthalmol Eye Dis       Date:  2014-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.